Diagnostic efficiency of hemoglobin A1c for newly diagnosed diabetes and prediabetes in community-based chinese adults aged 40 years or older

Diabetes Technology and Therapeutics

Volumn 16, Issue 12, 2014, Pages 853-857

  Liang, Kai ^a   Sun, Yu ^a   Li, Wen Juan ^a   Zhang, Xiu Ping ^b   Li, Cheng Qiao ^c   Yang, Wei Fang ^d   Ma, Ze Qiang ^e   Ma, Ai Xia ^a   Zheng, Hui Zhen ^a   Song, Jun ^a   Lin, Peng ^a   Hou, Xin Guo ^a   Chen, Li ^a  

^a SHANDONG UNIVERSITY   (China)

^b Shantui Community Health Center   (China)

^c the Second Hospital   (China)

^d Lukang Hospital   (China)

^e China National Heavy Duty Truck Corp   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; AUTOANALYZER; AUTOMATIC GLYCATED HEMOGLOBIN METER; BLOOD ANALYSIS EQUIPMENT; CHINESE; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; RECEIVER OPERATING CHARACTERISTIC; YOUDEN INDEX; ANALYSIS; BLOOD; CHINA; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 2; DIFFERENTIAL DIAGNOSIS; ETHNOLOGY; EVALUATION STUDY; GLUCOSE TOLERANCE TEST; HEALTH SURVEY; MIDDLE AGED; POSTPRANDIAL STATE; PRACTICE GUIDELINE; PREDIABETIC STATE; PREVALENCE; SENSITIVITY AND SPECIFICITY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CHINA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLUCOSE TOLERANCE TEST; HEALTH SURVEYS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; PRACTICE GUIDELINES AS TOPIC; PREDIABETIC STATE; PREVALENCE; SENSITIVITY AND SPECIFICITY;

EID: 84914180374     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2014.0157     Document Type: Article

References (20)

1. Yang WY, Lu JM, Weng JP, et al.: Prevalence of diabetes among men and women in China. N Engl J Med 2010;362: 1090-1101
2. Gregg EW, Cadwell BL, Cheng YJ, et al.: Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the U.S. Diabetes Care 2004; 27:2806-2812
3. Harris MI, Klein R, Welborn TA, et al.: Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 1992;15:815-819
4. Pan XR, Li GW, Hu YH, et al.: Effect of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care 1997;20:537-544
5. Tuomilehto J, Lindstrom J, Eriksson JG, et al.: Prevention of type 2 diabetes mellitus by change in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350
6. Selvin E, Crainiceanu CM, Brancati FL, et al.: Short-Term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med 2007;167: 1545-1551
7. Nathan DM, Buse JB, Davidson MB, et al.: Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetologia 2009;52:17-30
8. American Diabetes Association: Standards of medical care in Diabetes: 2010. Diabetes Care 2010;33(Suppl 1):S11-S61
9. International Expert Committee: International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327-1334
10. Ning G; Reaction Study Group: Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal (REACTION) study. J Diabetes 2012;4:172-173
11. Bi Y, Lu J, Wang W, et al.: Cohort profile: Risk evaluation of cancers in Chinese diabetic individuals: a longitudinal (REACTION) study. J Diabetes 2014;6:147-157
12. Lu J, Bi Y, Wang T, et al.: The relationship between insulinsensitive obesity and cardiovascular diseases in a Chinese population: Results of the REACTION study. Int J Cardiol 2014;172:388-394
13. World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation. www.staff.ncl.ac.uk/philip .home/whoffdmg.pdf (accessed March 12, 2013
14. Selvin E, Steffes MW, Zhu H, et al.: Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010;362:800-811
15. Bao Y, Ma X, Li H, et al.: Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey. BMJ 2010;340:c2249
16. Nakagami T, Tominaga M, Nishimura R, et al.: Is the measurement of glycated hemoglobin A1c alone an efficient diagnosing test for undiagnosed diabetes? Japan National Diabetes Survey. Diabetes Res Clin Pract 2007;76: 251-256
17. Kim JH, Kim GW, Lee MY, et al.: Role of HbA1c in the diagnosing of diabetes mellitus in a Korean rural community. Diabetes Metab J 2012;36:37-42
18. Hajat C, Harrison O, Al Siksek Z: Diagnostic testing for diabetes using HbA1c in the Abu Dhabi population: Weqaya: the Abu Dhabi cardiovascular screening program. Diabetes Care 2011;34:2400-2402
19. Zhou XH, Ji LN, Luo YY, et al.: Performance of HbA1c for detecting newly diagnosed diabetes and pre-diabetes in Chinese communities living in Beijing. Diabet Med 2009; 26:1262-1268
20. Helanza Y, Hara S, Arase Y, et al.: HbA1c 5.7-6.4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study. Lancet 2011;378:147-155